Document:

BP53866 -- Cygene --Exhibit 10.1

Exhibit 10.1

FORM OF STOCK OPTION AGREEMENT

THIS STOCK OPTION AGREEMENT (the “Agreement”) is entered into as of the ___ day of December, 2004, between CyGene Laboratories, Inc. (the “Company”) and __________________ (the “Optionee”).

WHEREAS, by action taken by the board of directors (the “Board”) of the Company, it has adopted the Restated 2004 Stock Plan (the “Plan”); and 

WHEREAS, by action taken by the Board it has been determined that in order to enhance the ability of the Company to attract and retain qualified [employees or directors], it has granted the Optionee the right to purchase common stock of the Company pursuant to non-qualified options.

NOW THEREFORE, in consideration of the mutual covenants and promises hereafter set forth and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties hereto agree as follows: 

1.

Grant of Non-Qualified Options.  The Company irrevocably grants to the Optionee, as a matter of separate agreement and not in lieu of salary or other compensation for services, the right and option (the “Options”) to purchase all or any part of an aggregate of __________ shares of 

1

authorized but unissued or treasury common stock of the Company on the terms and conditions herein set forth.  The common stock shall be unregistered unless the Company voluntarily files a registration statement covering such shares with the Securities and Exchange Commission.  

2.

Price.  The exercise price of the shares of common stock subject to the Options shall be $_______ which was the closing price of the Company’s common stock on the principal trading market on ____________[date], that date being the last trading day prior to the date on which the Options were granted to the Optionee. 

3.

Vesting-When Exercisable.  

(a)

The Options shall vest over _____ years in ______ increments on June 30 and December 31 of each year, commencing on _________, as long as the Optionee remains [employed or a director] on each applicable vesting date.  In lieu of fractional vesting, the number of Options shall be rounded up each time until fractional Options are eliminated.

(b)

Subject to Sections 3 (c) and 4 of this Agreement, Options may be exercised prior to vesting and remain exercisable for five years from the date of grant.

(c)

However, notwithstanding any other provision of this Agreement, all Options, whether vested or unvested shall be immediately forfeited in the event of:

2

(1)

Termination for any reason including without cause and including, but not limited to, fraud, theft, Optionee dishonesty and violation of Company policy;

(2)

Purchasing or selling securities of the Company without written authorization in accordance with the Company’s inside information guidelines then in effect;

(3)

Breaching any duty of confidentiality including that required by the Company’s inside information guidelines then in effect;

(4)

Competing with the Company;

(5)

Being unavailable for consultation after leaving the Company’s [employ or service as a director] if such availability is a condition of any agreement between the Company and the Optionee;

(6)

Recruitment of Company personnel after termination of Optionee’s [employment or service as a director], whether such termination is voluntary or for cause;

(7)

Failure to assign any invention or technology to the Company if such assignment is a condition of employment or any other agreements between the Company and the Optionee; or

(8)

A finding by the Company’s Board that the Optionee has acted against the interests of the Company.

3

4.

Termination of Relationship.

(a)

If for any reason, except death or disability as provided below, the Optionee ceases [to act as an employee or serve as a director] of the Company, all rights granted hereunder shall terminate effective three months from the date the Optionee ceases [to act as an employee or serve as a director], except as otherwise provided for herein.

(b)

If the Optionee shall die [while an employee of the Company or serving as a director], his estate or any Transferee, as defined herein, shall have the right within one year from the date of the Optionee’s death to exercise the Optionee’s vested Options subject to Section 3(c).  For the purpose of this Agreement, “Transferee” shall mean a person to whom such shares are transferred by will or by the laws of descent and distribution.

(c)

No transfer of the Options by the Optionee by will or by the laws of descent and distribution shall be effective to bind the Company unless the Company shall have been furnished with written notice thereof and a copy of the letters testamentary or such other evidence as the Board may deem necessary to establish the authority of the state and the acceptance by the Transferee or Transferees of the terms and conditions of the Options.

(d)

If the Optionee becomes disabled while employed by the Company within the meaning of Section 22(e)(3) of the Internal Revenue Code of 1986, the three month period referred to in Section 4(a) of this Agreement shall be extended to one year.

4

5.

Profits on the Sale of Certain Shares; Redemption.  If any of the events specified in Section 3(c) of this Agreement occur within one year from the last date of [employment or service as a director of the Company] (the “Termination Date”) (or such longer period required by any written employment agreement), all profits earned from the sale of the Company’s securities, including the sale of shares of common stock underlying Options, during the two-year period commencing one year prior to the Termination Date shall be forfeited and forthwith paid by the Optionee to the Company.  Further, in such event, the Company may at its option redeem shares of common stock acquired upon exercise of Options.  The Company’s rights under this Section 5 do not lapse one year from the Termination Date but are a contract right subject to any appropriate statutory limitation period.

6.

Method of Exercise.  The Options shall be exercisable by a written notice which shall:

(a)

state the election to exercise the Options, the number of shares to be exercised, the person in whose name the stock certificate or certificates for such shares of common stock is to be registered, his address and social security number (or if more than one, the names, addresses and social security numbers of such persons);

(b)

contain such representations and agreements as to the holder’s investment intent with respect to such shares of common stock as set forth in Section 11 hereof;

5

(c)

be signed by the person or persons entitled to exercise the Options and, if the Options are being exercised by any person or persons other than the optionee, be accompanied by proof, satisfactory to counsel for the Company, of the right of such person or persons to exercise the Options.

(d)

be accompanied by full payment of the purchase or exercise price therefor in United States dollars by check.

The certificate or certificates for shares of common stock as to which the Options shall be exercised shall be registered in the name of the person or persons exercising the Options.

7.

Sale of Shares Acquired Upon Exercise of Options.  Any shares of the Company’s common stock acquired pursuant to Options granted hereunder can be publicly sold by the Optionee in compliance with the Securities Act of 1933, subject to effectiveness of the Form S-8. 

8.

Anti-Dilution Provisions.  The Options granted hereunder shall have the anti-dilution rights set forth in the Plan.

9.

Necessity to Become Holder of Record.  Neither Optionee nor his/her estate, as provided in Section 4(c), shall have any rights as a stockholder with respect to any shares covered by the Options until such person shall have become the holder of record of such shares.  No adjustment shall be made for cash dividends or cash distributions, ordinary or extraordinary, in respect of such shares for which the record date is prior to the date on which he shall become the holder of record thereof.

6

10.

Reservation of Right to Terminate Relationship.  Nothing contained in this Agreement shall restrict the right of the Company to terminate the relationship of the Optionee at any time, with or without cause.  The termination of the relationship of the Optionee by the Company, regardless of the reason therefor, shall have the results provided for in Sections 4 and 5 of this Agreement.

11.

Conditions to Exercise of Options.  In order to enable the Company to comply with the Securities Act of 1933 (the “Securities Act”) and relevant state law, the Company may require the Optionee, his estate, or any Transferee, as a condition of the exercising of the Options granted hereunder, to give written assurance satisfactory to the Company that the shares subject to the Options are being acquired for his own account, for investment only, with no view to the distribution of same, and that any subsequent resale of any such shares either shall be made pursuant to a registration statement under the Securities Act and applicable state law which has become effective and is current with regard to the shares being sold, or shall be pursuant to an exemption from registration under the Securities Act and applicable state law.

The Options are subject to the requirement that, if at any time the Board shall determine, in its discretion, that the listing, registration, or qualification of the shares of common stock subject to the Options upon any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory body, is necessary as a condition of, or in connection with the issue or purchase of shares under the Options, the Options may not be exercised in whole or in part unless such listing, registration, qualification, consent or approval shall have been effected.  

7

12.

Duties of Company.  The Company shall at all times during the term of Options:

(a)

Reserve and keep available for issue such number of shares of its authorized and unissued common stock as will be sufficient to satisfy the requirements of this Agreement;

(b)

Pay all original issue taxes with respect to the issue of shares pursuant hereto and all other fees and expenses necessarily incurred by the Company in connection therewith;

(c)

Use its best efforts to comply with all laws and regulations which, in the opinion of counsel for the Company, shall be applicable thereto.

13.

Parties Bound by Plan.  The Plan and each determination, interpretation or other action made or taken pursuant to the provisions of the Plan shall be final and shall be binding and conclusive for all purposes on the Company and the Optionee and his/her respective successors in interest.

14.

Severability.  In the event any parts of this Agreement are found to be void, the remaining provisions of this Agreement shall nevertheless be binding with the same effect as though the void parts were deleted.

15.

Arbitration.  Any controversy, dispute or claim arising out of or relating to this Agreement, or its interpretation, application, implementation, breach or enforcement which the 

8

parties are unable to resolve by mutual agreement, shall be settled by submission by either party of the controversy, claim or dispute to binding arbitration in Broward County, Florida (unless the parties agree in writing to a different location), before a single arbitrator in accordance with the rules of the American Arbitration Association then in effect. The decision and award made by the arbitrator shall be final, binding and conclusive on all parties hereto for all purposes, and judgment may be entered thereon in any court having jurisdiction thereof.

16.

Benefit.  This Agreement shall be binding upon and inure to the benefit of the parties hereto and their legal representatives, successors and assigns.

17.

Notices and Addresses.  All notices, offers, acceptance and any other acts under this Agreement (except payment) shall be in writing, and shall be sufficiently given if delivered to the addressees in person, by Federal Express or similar receipted delivery, or by facsimile delivery as follows:

The Optionee:

_____________________

_____________________

_____________________

  

Facsimile (   ) __________

The Company:

CyGene Laboratories, Inc.

7786 Wiles Road

 

Coral Springs, Florida 33067

   

Facsimile (954) 741-7021

9

with a copy to:

Michael D. Harris, Esq.

Michael Harris, P.A.

1555 Palm Beach Lakes Blvd., Suite 310

West Palm Beach, FL  33401

Facsimile:  (561) 478-1817

or to such other address as either of them, by notice to the other may designate from time to time.  The transmission confirmation receipt from the sender’s facsimile machine shall be evidence of successful facsimile delivery.  Time shall be counted to, or from, as the case may be, the delivery in person or by mailing.

18.

Attorney’s Fees.  In the event that there is any controversy or claim arising out of or relating to this Agreement, or to the interpretation, breach or enforcement thereof, and any action or proceeding is commenced to enforce the provisions of this Agreement, the prevailing party shall be entitled to a reasonable attorney’s fee, costs and expenses.

19.

Governing Law.  This Agreement and any dispute, disagreement, or issue of construction or interpretation arising hereunder whether relating to its execution, its validity, the obligations provided herein or performance shall be governed or interpreted according to the internal laws of the State of Delaware without regard to choice of law considerations.  

20.

Oral Evidence.  This Agreement constitutes the entire Agreement between the parties and supersedes all prior oral and written agreements between the parties hereto with respect to the 

10

subject matter hereof.  Neither this Agreement nor any provision hereof may be changed, waived, discharged or terminated orally, except by a statement in writing signed by the party or parties against which enforcement or the change, waiver discharge or termination is sought.

21.

Counterparts.  This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.  The execution of this Agreement may be by actual or facsimile signature.

22.

Additional Documents.  The parties hereto shall execute such additional instruments as may be reasonably required by their counsel in order to carry out the purpose and intent of this Agreement and to fulfill the obligations of the parties hereunder.

23.

Section or Paragraph Headings.  Section headings herein have been inserted for reference only and shall not be deemed to limit or otherwise affect, in any matter, or be deemed to interpret in whole or in part any of the terms or provisions of this Agreement.

11

IN WITNESS WHEREOF the parties hereto have set their hand and seals the day and year first above written.

WITNESSES:

CYGENE LABORATORIES, INC.

_______________________________

By:

_________________________________

Martin Munzer,

President and Chief Executive Officer

OPTIONEE

______________________________

________________________________

12December 13 2004 Exhibit 10.1

                                                                                          Exhibit 10.1 

PATENT PURCHASE AGREEMENT

THIS PATENT PURCHASE AGREEMENT ("Agreement") is made as of
December 10, 2004 ("Effective Date"), by Commerce One
Operations, Inc., a corporation organized under the laws of Delaware, with an
address at 580 California Street, Suite 526, San Francisco, California 94104
("Seller") and JGR Acquisition, Inc., a company existing
pursuant to the laws of Delaware, with an address at 1201 North Market Street,
PO Box 1347, Wilmington, Delaware 19899 ("Purchaser").

In consideration of the mutual agreements and understandings set forth
herein, and for other good and valuable consideration, the adequacy of which is
hereby acknowledged, the parties to this Agreement hereby agree as follows:

	Effective as of the Closing (as defined below), Seller hereby irrevocably
sells, transfers, conveys and assigns to Purchaser, and Purchaser shall acquire
from Seller all of Seller's right, title and interest in and to and under
all Assigned Patents (as defined below), including all past and future income,
royalties, damages and payments due (including, rights to damages and payments
for past, present or future infringements or misappropriations) with respect
thereto, in each case, of Seller in all countries relating to such Assigned
Patents (collectively the "Purchased Assets"), free and clear
of all liens, claims, encumbrances and UCC filings, but subject to the rights in
the Purchased Assets granted to Mitsubishi Corporation in the Agreement for
Intellectual Property Rights License and Mutual Waiver and Release of Liability
Under Intellectual Property Rights between Commerce One Operations, Inc. and
Mitsubishi Corporation dated December 19, 2003, attached hereto as Exhibit
D.  

The term "Assigned Patents" shall mean all Patents listed on the
accompanying Exhibit A and all continuations, continuations-in-part,
divisionals, patent cooperation treaty equivalents, and foreign counterparts of
the Patents listed on the accompanying Exhibit A.

The term "Patents" shall mean any United States or foreign patents
and applications (including provisional applications), patents issuing from such
applications, certificates of invention or any other grants by any court,
administrative agency or commission or other federal, state, county, local or
foreign governmental authority, instrumentality, agency commission or
subdivision thereof, including the U.S. Patent and Trademark Office
("PTO") and the European Patent Office
("EPO"), for the protection of inventions, or foreign
equivalents of any of the foregoing.

	Purchase Price: Purchaser will purchase the Purchased Assets for a total
value of Fifteen Million Five Hundred Thousand U.S. Dollars ($15,500,000).
Consideration will consist of a payment of such amount by wire transfer to an
account of Seller's specification at the Closing.

  

	Conditions to be Met Prior to Closing:  The following are conditions
precedent to the Closing and to Purchaser's obligation to make the payments
contemplated by Section 2 of this Agreement:  

	Execution and conveyance by Seller of an assignment of the Purchased Assets
in the form set forth in Exhibit B to this Agreement and any other
recording documents associated therewith.  Notwithstanding the foregoing, such
patent assignments shall only be recorded after the wire transfer (to be
provided under Section 2) is received by Seller.
	Execution of that certain Patent License Agreement by and among Seller and
Purchaser dated December 10, 2004 attached hereto as Exhibit C (the
"License Agreement").
	The United States Bankruptcy Court shall have entered an Order approving
execution, delivery and performance by Seller of the terms and conditions of
this Agreement.

	Miscellaneous:  Both before and after the Closing (as defined below), each
party shall, without the requirement of any additional consideration, execute
and/or cause to be delivered to each other party such other instruments and
recording documents, and shall take such other actions, as may be necessary to
carry out or evidence this Agreement and record the contemplated patent
assignment with the United States Patent and Trademark Office and any foreign
patent office(s).  Seller hereby irrevocably transfers, conveys and assigns to
Purchaser, and Purchaser accepts from Seller, all of Seller's right, title and
interest in and to and under the Inventor Agreements, except that such transfer,
conveyance, and assignment shall not extend to any right under any such
Agreement that does not relate specifically to one of the Assigned Patents. As
used herein, the term Inventor Agreements means any agreement by which an
inventor on any of the Assigned Patents is obligated to assist Seller in any way
with regard to the filing, prosecution, issuance, or maintenance of any of the
Assigned Patents.
	Closing:  When all of the conditions herein have been waived or satisfied,
the closing of the sale of the Purchased Assets (the "Closing")
shall occur within two (2) business days, but no later than December 23,
2004.
	Representations and Warranties: Each party represents and warrants to the
other that (i) such party including those signatory herewith have the full
power and authority to enter into, execute and deliver this Agreement and
perform the obligations contained herein; (ii) the execution and delivery by
such party of this Agreement and the performance by such party of its
obligations contemplated in this Agreement have been duly authorized by any
necessary corporate or other action of such party; and (iii) the execution,
delivery and performance of this Agreement by such party will not conflict with
or result in any material breach or violation of any of the terms and conditions
of, or constitute a default under, any instrument, contract or other agreement
to which such party is a party or by which such party is bound. Seller further
represents and warrants to Purchaser that Seller is the beneficial and
registered owner of the Purchased Assets. Purchaser further represents and
warrants to Seller that Purchaser has the ability to and will license the
Purchased Assets to Seller and that Seller can then assign Seller's Rights under
the License Agreement to Commerce Acquisition, LLC pursuant to the terms of the
License Agreement; provided, however, that Purchaser shall have no liability
under this sentence for any deficiencies in Purchaser's ability to license the
Purchased Assets to Seller that are caused by any deficiency in Seller's rights
in the Purchased Assets or in Seller's conveyance thereof to Purchaser.
	NO WARRANTY; NO RECOURSE.  EXCEPT AS EXPRESSLY SET FORTH IN SECTION 6 ABOVE,
THE RIGHTS GRANTED TO PURCHASER HEREUNDER ARE PROVIDED STRICTLY ON AN "AS
IS" BASIS, WITHOUT ANY WARRANTIES OF ANY KIND WHATSOEVER, WHETHER EXPRESS,
IMPLIED, STATUTORY OR OTHERWISE AND SELLER HEREBY EXPRESSLY DISCLAIMS ANY AND
ALL IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND
NON-INFRINGEMENT.  Purchaser specifically acknowledges and agrees that Purchaser
and its successors and assignees will not have any recourse to, or any right to
bring a claim or action against, any of the agents, representatives, employees,
officers or directors of Seller (as opposed to the Seller as an entity and
Seller's affiliated entities) in the event that (i) any representations and
warranties or other statements made by or on behalf of Seller are untrue as of
the time of their expression or as of the Closing, or (ii) Seller does not
fulfill any of its covenants or other obligations in this Agreement or any
related agreement or document. 
	Expenses: Unless otherwise specified herein, each party will bear its own
costs and expenses in connection with the transactions contemplated hereby.
	Integration: The provisions of this Agreement shall constitute binding and
enforceable contractual obligations and this Agreement along with Exhibits A, B
and C, shall constitute the entire agreement between the parties, shall
supersede any prior understanding, agreement, or representations by or between
the parties whether written or oral, that may have related to the subject matter
hereof, and shall inure to the benefit of their respective successors and
assigns.  This Agreement may be modified in writing only, signed by the parties
at the time of the modification.  No failure or delay on the part of any party
in exercising any of its respective rights hereunder shall operate as a waiver
thereof, nor shall any single or partial exercise of any such rights preclude
any other or further exercise thereof or the exercise of any other rights
hereunder.
	Counterparts:  This Agreement may be executed in one or more counterparts,
all of which taken together shall constitute one and the same instrument.
	Governing Law:  This Agreement shall be governed by
and construed and enforced in accordance with the laws of the State of
California applicable to agreements made and to be performed entirely in
California.  

 

[Remainder of Page Intentionally Left Blank]

IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to
be executed on its behalf by its duly authorized officer, all as of the
Effective Date.

	
SELLER

By:_______________________________

Name:_____________________________

Title:______________________________
	
PURCHASER

By:_______________________________

Name:_____________________________

Title:______________________________ 

 

EXHIBIT A

PURCHASED ASSETS

EXHIBIT B

FORM OF PATENT ASSIGNMENT

PATENT ASSIGNMENT

THIS PATENT ASSIGNMENT is made as of December 10, 2004, from Commerce
One, Inc., a Corporation organized under the laws of Delaware, with an address
at 580 California Street, Suite 526, San Francisco, California 94104
("Assignor") to JGR Acquisition, Inc., a company existing
pursuant to the laws of Delaware, with an address at 1201 North Market Street,
PO Box 1347, Wilmington, Delaware 19899 ("Assignee").

WHEREAS, Assignor is the owner of the patents and patent
applications (the "Patents") set forth in Schedule A
attached hereto.

WHEREAS, Assignor and Assignee have entered into a Patent
Purchase Agreement dated as of December 10, 2004, pursuant to which Assignor has
agreed, inter alia, to grant and assign to Assignee all of Assignor's
right title and interest in and to the Patents and Assignee desires to acquire
the entire right, title and interest in and to the Patents.

NOW, THEREFOR, in consideration of the foregoing and for other good and
valuable consideration, the receipt and sufficiency of which are hereby
acknowledged:

I.Assignor hereby irrevocably sells, transfers, conveys
and assigns unto Assignee, its successors and assigns, Assignor's entire right,
title and interest in and to the Patents and any continuations, divisions,
reissues, or extensions of the Patents, including all past and future income,
royalties, damages and payments due (including, rights to damages and payments
for past, present or future infringements or misappropriations) with respect
thereto, in each case, of Assignor in all countries relating to the Patents.

II.Assignor hereby authorizes the Commissioner of Patents
and Trademarks of the United States and other empowered officials of the United
States Patent and Trademark Office and/or the appropriate empowered officials
other relevant jurisdictions outside the United States to record the transfer of
the Patents to Assignee as assignee of Assignor's entire right, title and
interest therein, in accordance with this Patent Assignment, and to issue to
Assignee all letters patent which may issue with respect to the Patents.

 

 

 

[Signature Page to Follow]

IN WITNESS WHEREOF, Assignor has caused these presents to be
duly executed in a manner appropriate thereto as of the date first above
written.
Assignor: COMMERCE ONE, INC. 

By: 

Name: 

Title:  

 

ACKNOWLEDGMENT

February [__], 2004

State of ________)

) ss:

County of ______)

On this ___th day of ________ 20__, before me, the
undersigned, personally appeared ___________________________, �
 personally known to me - OR - �
 proved to me on the basis of satisfactory evidence to be the person(s) whose
name(s) is/are subscribed to the within instrument and acknowledged to me that
he/she/they executed the same in his/her/their authorized capacity(ies), and
that by his/her/their signature(s) on the instrument the person(s), or the
entity upon behalf of which the person(s) acted, executed the instrument.

WITNESS my hand and official seal.

Signature:     (Seal)
Notary Public

 

Schedule A

LIST OF PATENTS

	
Item
	
Application Number

	
Computer System to Compile Non-Incremental Computer Source Code
to Execute Within an Incremental Type Computer System
	
5,884,083

	
Computer System to Compile Non-Incremental Computer Source Code
to Execute Within an Incremental Type Computer System
	
6,687,896

	
Documents For Commerce in Trading Partner Networks and Interface
Definitions Based on the Documents
	
09/173,858

	
Participant Server Which Processes Documents for Commerce in
Trading Partner Networks
	
6,226,675

	
Market Makers Using Documents for Commerce in Trading Partner
Networks
	
6,125,391

	
Enterprise System That Incorporates Business Process Life Cycle
Management Capabilities
	 
	
Commerce Community Schema for the Global Trading Web
	
10/111,995

	
System and method for schema evolution in an e-commerce
network
	
09/493,517

	
Method of retrieving schemas for interpreting documents in an
electronic commerce system
	
6,591,260

	
Method for Automatic Categorization of items
	
6,751,600

	
Registry for trading partners using documents for commerce In
trading partner networks
	
09/633,365

	
System and Method for Integrating Data Sources Based Upon
Attribute Dimensions
	 
	
Integration of Data Sources Sharing a Large Homogeneous Schema
Template
	 
	
Fully Functional Self-Contained Electronic Marketplace Training
Environment
	 
	
System and Method for Graphically Mapping Source Schemas to a
Target Schema
	 
	
System and Method for Effectively Implementing a Marketsite
Application Integrator
	 
	
Method and apparatus for declarative updating of self-
describing, structured documents
	
10/026,364

	
Method and apparatus for declarative error handling and
presentation
	
10/026,366

	
Method and apparatus for generic search interface across
document types
	
10/026,681

	
SCL (scenario configuration language) for a rule based
system
	
10/105,015

	
Data Syndication and Synchronization
	
10/128,985

	
Methodology for Dynamically Presenting Information to a System
User of an Electronic Device
	 
	
Registry Driven Interoperability and Exchange of
Documents
	 
	
Electronic Commerce Community Networks and Intra/Inter Community
Secure Routing Implementation
	 
	
Commerce Community Schema for the Global Trading Web
	
60/163,020

	
Method and apparatus for viewing electronic commerce-related
documents
	
09/794,302

	
Method and device utilizing polymorphic data in e-
commerce
	
09/730,489

	
Tools for building documents for commerce in trading partner
networks and interface definitions
	
6,542,912

	
Xcbl mailbox methods and devices
	
10/026,663

	
System and Method for Effectively Implementing A Marketsite
Application Integrator
	
10/302,221

	
System and Method for Effectively Configuring a Marketsite
Application Integration Architecture
	
10/302,327

	
System and Method for Effectively Performing Overflow Data
Procedure
	
10/314,701

	
Electronic Commerce Community Networks and Intra/Inter Community
Secure Routing Implementation
	
10/199,967

	
XML Streaming Transformer
	
10/222,752

	
Dynamic Interoperability Contract for Web Services
	
10/246,592

	
Registry Driven Interoperability and Exchange of
Documents
	
10/199,963

	
Exposing Process Flows and Choreography Controllers as Web
Services
	
10/246,512

	
Transparent EJB Support and Horizontal Data
Partitioning
	
10/281,914

	
Dynamic Interface Between BPSS Conversation Management and Local
Business Management
	
10/222,008

	
Dynamic Negotiation of Security Arrangements Between Web
Services
	
10/246,276

 

 

EXHIBIT C

PATENT LICENSE AGREEMENT

EXHIBIT D

LICENSE AGREEMENT WITH MITSUBISHI

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}]]